Bioaffinity Technologies Inc (BIAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Sales | 9,362 | 2,533 | 5 | 0 | 0 |
| Cost of Goods | 5,984 | 1,741 | 1 | 0 | N/A |
| Gross Profit | 3,379 | 792 | 4 | 0 | N/A |
| Operating Expenses | 13,316 | 9,506 | 4,016 | 2,207 | 0 |
| Operating Income | -8,953 | -7,973 | -4,011 | -2,207 | N/A |
| Interest Expense | 93 | 37 | 2,533 | 1,002 | 0 |
| Other Income | 18 | 94 | -1,608 | -3,116 | 0 |
| Pre-tax Income | -9,028 | -7,916 | -8,152 | -6,325 | 0 |
| Income Tax | 12 | 21 | 3 | -2 | N/A |
| Net Income Continuous | -9,040 | -7,937 | -8,154 | -6,323 | N/A |
| Net Income | $-9,040 | $-7,937 | $-8,154 | $-6,323 | $N/A |
| EPS Basic Total Ops | -22.52 | -27.33 | -54.35 | -70.87 | N/A |
| EPS Basic Continuous Ops | -22.39 | -27.25 | -54.43 | -70.97 | N/A |
| EPS Diluted Total Ops | -22.52 | -27.33 | -54.35 | -70.87 | N/A |
| EPS Diluted Continuous Ops | -22.39 | -27.25 | -54.43 | -70.97 | N/A |
| EPS Diluted Before Non-Recurring Items | -22.52 | -27.33 | -54.35 | -70.87 | N/A |
| EBITDA(a) | $-8,348 | $-7,724 | $-1,945 | $-1,721 | $N/A |